You are viewing: South Korea Long Read Sequencing Market analysis
Part of: Long Read Sequencing Market (Global)

The South Korea Long Read Sequencing Market was valued at $3.3 Million in 2024 and projected to reach to $10.3 Million by 2029, representing a compound annual growth rate of 25.5%. South Korea's long read sequencing market is poised for significant growth over the next five years, driven by the country's commitment to genomic research and precision medicine development.

South Korea Long Read Sequencing Market (2024-2029) : Size and Share
logo-mobile
CAGR of
cagr-Chart
USD Million
MARKET SNAPSHOT
Market Size in USD 26.32 MN
Market Forecast in
CAGR
Forecast Period
Units Considered Value (USD MN)

South Korea Long Read Sequencing Market Trends and Insights

  • This expansion reflects South Korea's strong investment in genomic research infrastructure and its position as a leading biotechnology hub in Asia Pacific.
  • South Korea's healthcare sector is increasingly adopting long read sequencing technologies for clinical diagnostics, rare disease identification, and precision medicine applications. The 25.5% compound annual growth rate demonstrates South Korea's commitment to advancing sequencing capabilities and genomic innovation.
  • South Korea's research institutions and pharmaceutical companies are driving demand through collaborative projects and clinical implementations.
  • By 2029, South Korea is expected to solidify its role as a key market for long read sequencing adoption, supported by government funding initiatives and growing private sector participation in genomic research..

Key Market Statistics

  • CAGR (2024-2029) 25.5% CAGR
  • Market Size, 2024 ~USD 3.3 Million
  • Forecast, 2029 ~USD 10.3 Million
  • Country South Korea

South Korea Long Read Sequencing Market Overview

Rapid Market Expansion :

South Korea's long read sequencing market is projected to grow from $3.3 million in 2024 to $10.3 million by 2029, representing a robust 25.5% CAGR, driven by increased genomic research investments and healthcare sector adoption.

Asia Pacific Biotech Leadership :

South Korea has established itself as a leading biotechnology hub in Asia Pacific, with strong government support for genomic research infrastructure and advanced healthcare technology adoption accelerating long read sequencing implementation.

Healthcare Sector Integration :

South Korea's healthcare system is increasingly integrating long read sequencing technologies into clinical diagnostics and research applications, supported by the country's advanced medical infrastructure and digital health initiatives.

Strategic Research Investment :

Government and private sector investments in genomic research facilities and precision medicine initiatives are positioning South Korea as a key market for long read sequencing technology adoption and innovation.

South Korea Long Read Sequencing Market Dynamics

  • The market's 25.5% CAGR reflects strong demand from research institutions, diagnostic laboratories, and healthcare providers seeking advanced sequencing capabilities.
  • South Korea's position as a biotechnology leader in Asia Pacific, combined with substantial government funding for life sciences research, creates favorable conditions for market expansion.
  • The healthcare sector's increasing adoption of long read sequencing for rare disease diagnosis and cancer genomics research will further accelerate market penetration and technology integration across clinical and research settings..

Related Ecosystem

Biotechnology

Top Technologies
  • Reagents
  • Polymerase Chain Reaction (PCR)
  • Stem Cells
  • Assay Kits
  • Flow Cytometers
Top Companies
  • Thermo Fisher Scientific Inc.
  • Merck KGaA
  • Danaher Corporation
  • Agilent Technologies, Inc.
  • Bio-Rad Laboratories, Inc.

    Key Takeaways

    • South Korea's long read sequencing market is valued at $3.3 million in 2024 with a projected value of $10.3 million by 2029.
    • South Korea demonstrates a 25.5% CAGR, reflecting strong adoption of advanced genomic technologies in clinical and research settings.
    • South Korea's healthcare infrastructure and government support are key drivers of market expansion in precision medicine and rare disease diagnostics.
    • South Korea is positioned as a leading Asia Pacific market for long read sequencing, attracting investment from both domestic and international biotechnology firms.

    Long Read Sequencing Market Report Scope

    Report Metric Details
    Base Year 2024
    Fastest Growing Segment DATA ANALYSIS (Workflow)
    Forecast Period 2024-2029
    Growth Rate CAGR of 32.8% from 2024 to 2029
    Largest Segment RESEARCH USAGE (Usage)
    Market Size Base Year (Billions) ~USD 0.76 (2024)
    Revenue Forecast (Billions) ~USD 3.13 (2029)
    Segments Covered Offering, Technology, Workflow, Application, Usage, End User

    South Korea Long Read Sequencing Market Report Segmentation

    6 segment dimensions are covered across the global market.

    By Offering

    • Consumables
    • Instruments
    • Services

    By Technology

    • Nanopore Sequencing
    • Single-Molecule Real-Time Sequencing
    • Synthetic Long-Read Sequencing

    By Workflow

    • Data Analysis
    • Sample Preparation
    • Sequencing

    By Application

    • Epigenetics
    • Metagenomics
    • Other Applications
    • Targeted Sequencing
    • Whole-Exome Sequencing
    • Whole-Genome Sequencing

    By Usage

    • Clinical Usage
    • Research Usage

    By End User

    • Academic & Research Institute
    • Academic & Research Institutes
    • Hospitals, Clinics & Diagnostic
    • Hospitals, Clinics, And Diagnostic Labs
    • Other End User
    • Other End Users
    • Pharmaceutical & Biotechnologies Companies
    • Pharmaceutical & Biotechnology Companies
    • Pharmaceutical & Biotechnology Companies Labs

    Target Audience

    • Biotech Companies & Sequencing Vendors : Manufacturers and distributors of long read sequencing platforms need South Korea market data to identify expansion opportunities, assess competitive positioning, and develop localized go-to-market strategies in this high-growth biotech hub.
    • Healthcare & Diagnostic Providers : Clinical laboratories, diagnostic centers, and hospital systems in South Korea require market insights to evaluate long read sequencing adoption, benchmark against peers, and justify technology investments to stakeholders.
    • Research Institutions & Universities : Genomic research centers and academic institutions need market intelligence to secure funding, identify collaboration opportunities, and align research initiatives with South Korea's precision medicine and biotech development priorities.
    • Investment & Consulting Firms : Venture capital, private equity, and management consulting firms require detailed South Korea market analysis to evaluate investment opportunities, assess portfolio companies, and advise clients on biotech sector growth potential.
    • Government & Policy Organizations : South Korean health ministries, research councils, and policy bodies need market data to inform biotech strategy, allocate research funding, and develop regulatory frameworks supporting long read sequencing adoption.

    Reasons to Buy this Report

    • Market Size & Growth Data : Access precise valuation of South Korea's long read sequencing market with verified 2024-2029 forecasts, enabling accurate investment planning and competitive positioning in this high-growth Asia Pacific market segment.
    • Regional Competitive Intelligence : Understand South Korea's unique market dynamics, including government biotech initiatives, healthcare adoption rates, and research infrastructure investments that differentiate it from other Asia Pacific markets.
    • Strategic Market Entry Insights : Identify key opportunities for market entry and expansion in South Korea's genomic research and clinical diagnostics sectors with data-driven insights on adoption trends and stakeholder priorities.
    • Investment Decision Support : Leverage comprehensive South Korea market analysis to support venture capital, private equity, and corporate investment decisions in the long read sequencing technology and biotech sectors.
    • Stakeholder Benchmarking : Benchmark your organization's performance against South Korea market trends, identify growth opportunities, and align product development strategies with regional healthcare and research sector demands.

    Frequently asked questions

    What is the current market size of long read sequencing in South Korea?

    South Korea's long read sequencing market was valued at $3.3 million in 2024 and is expected to grow to $10.3 million by 2029.

    What is the growth rate of South Korea's long read sequencing market?

    South Korea's long read sequencing market is growing at a compound annual growth rate (CAGR) of 25.5% from 2024 to 2029.

    What are the primary drivers of growth in South Korea's long read sequencing market?

    South Korea's market growth is driven by increased investment in genomic research, government support for precision medicine, rising adoption in clinical diagnostics, and strong pharmaceutical and biotech sector participation.

    Which applications are driving demand for long read sequencing in South Korea?

    South Korea's demand is primarily driven by clinical diagnostics, rare disease identification, cancer genomics research, and precision medicine applications in healthcare institutions.

    How does South Korea's long read sequencing market compare to other Asia Pacific countries?

    South Korea is positioned as a leading market in Asia Pacific due to its advanced healthcare infrastructure, strong biotechnology sector, government funding for genomic research, and high adoption rates of innovative sequencing technologies.

    RESEARCH METHODOLOGY

    This study on the long-read sequencing market employed secondary sources, directories, and databases to gather pertinent information. To gather and validate important qualitative and quantitative data and evaluate market growth prospects, in-depth interviews were conducted with many primary respondents including key industry participants, subject-matter experts (SMEs), C-level executives from key market players, and industry consultants. After estimating the long-read sequencing market using several research strategies, the size of the final market was obtained by triangulating data from primary research.

    Secondary Research

    The secondary sources referred to for this research study include publications from government sources. These include Nucleic Acids Research, Genome Biology, Nature Reviews Genetics, Nature Methods, Genome Research, International Journal of Genomics, National Human Genome Research Institute (NHGRI), International Chromosome and Genome Society (ICGS), Genome Canada, European Society of Human Genetics (ESHG), Genomics England, Genome British Columbia, Beijing Institute of Genomics, Centre for Cellular & Molecular Biology (CCMB), São Paulo Research Foundation (FAPESP), National Cancer Institute (NCI), European Medicines Agency (EMA), Biotechnology and Biological Sciences Research Council (BBSRC), Organisation for Economic Co-operation and Development (OECD), Population Health Research Institute (PHRI),  PubMed, World Bank, and the World Health Organization (WHO), among others. Secondary sources also included corporate & regulatory filings, such as annual reports, SEC filings, investor presentations, and financial statements; business magazines & research journals; press releases; and trade, business, and professional associations. Secondary data was collected and analyzed to arrive at the overall size of the global long-read sequencing market, which was validated through primary research.

    Primary Research

    Extensive primary research was conducted after acquiring basic knowledge about the global long-read sequencing market scenario through secondary research. Several primary interviews were conducted with market experts from the supply side, such as C-level and D-level executives, operational managers, marketing & sales managers of key manufacturers, distributors, and channel partners of companies providing long-read sequencing; experts from the demand side, such as personnel from academic & research institutes, hospitals, clinics and diagnostic labs, pharmaceutical & biopharmaceutical industries. These interviews were conducted across six major regions, including North America, Europe, the Asia Pacific, Latin America, the Middle East, and Africa. Approximately 70% and 30% of the primary interviews were conducted with supply-side and demand-side participants, respectively. This primary data was collected through questionnaires, e-mails, online surveys, personal interviews, and telephonic interviews.

    The following is a breakdown of the primary respondents:

    Long Read Sequencing Market Size, and Share

    To know about the assumptions considered for the study, download the pdf brochure

    Market Size Estimation

    Both top-down and bottom-up approaches were used to estimate and validate the total size of the long-read sequencing market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:

    Bottom-up Approach

    • The key players in the industry and market have been identified through extensive secondary research.
    • The revenues generated from the long-read sequencing market business of leading players have been determined through primary and secondary research.
    • All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources.

    Long Read Sequencing Market Size, and Share

    To know about the assumptions considered for the study, Request for Free Sample Report

    Top-down Approach

    After arriving at the overall market size from the market size estimation process, the total market was split into several segments and subsegments.

    Long Read Sequencing Market Size, and Share

    Data Triangulation

    To complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides.

    Market Definition

    Long-read sequencing is a type of nucleic acid sequencing that produces genomic data by generating individual reads from single molecules, generally ranging in size from 700 to over 20,000 bases. These fragments are typically derived from "native" molecules, which are directly extracted from biological samples for analysis. The long-read sequencing market encompasses the consumables, instruments, services, and technology associated with long-read sequencing. The long-read sequencing market is defined as solutions including instruments/systems, consumables (kits, reagents, flow cells), and services for long-read sample preparation, sequencing, and data analysis. Long-read software solutions are often provided alongside the instrument/system/platform, hence the software solutions are considered within the instrument segment scope. Other standalone software solutions are provided as data analysis services and are considered within the services segment scope.

    Stakeholders

    • Academic & Research Institutes
    • Software & Bioinformatics Companies
    • Healthcare & Clinical Laboratories
    • Long-Read Sequencing Technology Vendors
    • Contract Research Organizations (CROs)
    • Market Research and Consulting Firms
    • Pharmaceutical & Biotechnology Companies
    • Regulatory Agencies
    • Venture Capitalists
    • Government Organizations
    • Industry Associations and Professional Societies

    Report Objectives

    • To define, describe, and forecast the long-read sequencing market based on offerings, technology, workflow, application, usage, end user, and region
    • To provide detailed information regarding the major factors influencing the market growth (such as drivers, restraints, opportunities, and challenges)
    • To strategically analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall long-read sequencing market
    • To analyze the opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
    • To forecast the size of the market segments with respect to six main regions, namely, North America, Europe, the Asia Pacific, Latin America, the Middle East, and Africa
    • To profile the key players in the global long-read sequencing market and comprehensively analyze their instruments, consumables, and services portfolios, market positions, and core competencies
    • To track and analyze competitive developments such as product & service launches, expansions, agreements, and collaborations in the long-read sequencing market
    • To benchmark players within the long-read sequencing market using the ‘Company Evaluation Matrix' framework, which analyzes market players based on various parameters within the broad categories of business and service strategy

    Available Customizations

    With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the report:

    Geographical Analysis

    • Further breakdown of the Rest of Europe Long-Read Sequencing Market, by country
    • Further breakdown of the Rest of Asia Pacific Long-Read Sequencing Market, by country
    • Further breakdown of the Rest of Latin America Long-Read Sequencing Market, by country
    • Further breakdown of the Rest of Middle East Long-Read Sequencing Market, by country

    Company Information

    • Detailed analysis and profiling of additional market players (up to five)

    Segment Analysis

    • Further breakdown of the other application and other end users area into subsegments
    • Cross-segment analysis

    Get the Full Long Read Sequencing Market Report

    Full forecast, segment splits, and company analysis for all Long Read Sequencing Market.

    Need a Tailored Report?

    Customize this report to your needs

    Get 10% FREE Customization

    Customize This Report
    Fact checked
    DMCA.com Protection Status